Tandem high-dose chemotherapy with ifosfamide, carboplatin, and teniposide with autologous bone marrow transplantation for the treatment of poor prognosis common epithelial ovarian carcinoma
- 15 June 1996
- Vol. 77 (12) , 2550-2559
- https://doi.org/10.1002/(sici)1097-0142(19960615)77:12<2550::aid-cncr19>3.0.co;2-r
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Global Cerebral Ischemia in the Rat: Online Monitoring of Oxygen Free Radical Production Using Chemiluminescence in vivoJournal of Cerebral Blood Flow & Metabolism, 1995
- Phase II trial of paclitaxel in patients with progressive ovarian carcinoma after platinum-based chemotherapy: a Gynecologic Oncology Group study.Journal of Clinical Oncology, 1994
- Protracted oral etoposide in epithelial ovarian cancer: a phase II study in patients with relapsed or platinum-resistant diseaseBritish Journal of Cancer, 1994
- Paclitaxel for platinum-refractory ovarian cancer: results from the first 1,000 patients registered to National Cancer Institute Treatment Referral Center 9103.Journal of Clinical Oncology, 1993
- Radical surgical procedure improves survival time in patients with recurrent ovarian cancerCancer, 1992
- Concomitant whole-abdominal radiation and intraperitoneal chemotherapy in advanced ovarian carcinoma. A pilot studyCancer, 1991
- Autologous Bone Marrow TransplantationAnnals of Internal Medicine, 1989
- Common Epithelial Cancer of the OvaryNew England Journal of Medicine, 1985
- Common Epithelial Cancer of the OvaryNew England Journal of Medicine, 1985
- Dose: A critical factor in cancer chemotherapyThe American Journal of Medicine, 1980